TickerKhojComparison · NSE · data 2026-11-02
Ajanta Pharma Limited vs Emcure Pharmaceuticals Limited
In plain words
Size: Ajanta Pharma Limited is about 1.2 times the market value of Emcure Pharmaceuticals Limited.
Return on equity: Ajanta Pharma Limited 25.4% vs Emcure Pharmaceuticals Limited 19.7%.
Debt to equity: Emcure Pharmaceuticals Limited 0.31 vs Ajanta Pharma Limited 0.06.
Differences in the numbers, not a recommendation of either stock.
Side by side
| AJANTPHARM | EMCURE | |
|---|---|---|
| Price | ₹3,438.9 | ₹1,874.2 |
| Market cap | ₹43,891 cr | ₹35,440 cr |
| P/E | 34.1 | 35.1 |
| P/B | 8.8 | — |
| ROE | 25.4% | 19.7% |
| ROCE | 30.0% | 22.6% |
| Debt / equity | 0.06 | 0.31 |
| Operating margin | 25.4% | 15.2% |
| Dividend yield | 1.71% | 0.19% |
| Sales growth, 3 years (yearly) | 13.3% | 15.4% |
| Profit growth, 3 years (yearly) | 21.6% | 20.2% |
| 1-year return | 39.3% | 40.9% |
| Revenue, last 12 months | ₹6,217 cr | ₹9,683 cr |
| Net profit, last 12 months | ₹1,263 cr | ₹1,011 cr |
| Latest quarter | Sept 2026 | Jun 2026 |
| Quarter net profit | ₹388 cr | ₹294 cr |
| Quarter profit vs a year earlier | +49.2% | +42.1% |
| Promoter holding | 63.47% | 77.82% |
| Health check | Strong (8.8/10) | Strong (8.5/10) |
Common questions
Which has a higher P/E, Ajanta Pharma Limited or Emcure Pharmaceuticals Limited?
Emcure Pharmaceuticals Limited trades at the higher P/E (35.1 against 34.1). A higher P/E means the market pays more for each rupee of past earnings; on its own it does not say which is better.
Which earns a higher return on equity?
Ajanta Pharma Limited (25.4% against 19.7%).
Which carries more debt?
Emcure Pharmaceuticals Limited has the higher debt-to-equity ratio (0.31 against 0.06).